Related references
Note: Only part of the references are listed.Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses
K-W Peng et al.
GENE THERAPY (2013)
Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth
Hooi-Tin Ong et al.
JOURNAL OF HEPATOLOGY (2013)
Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL
Max S. Topp et al.
BLOOD (2012)
Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model
B. Thaci et al.
CANCER GENE THERAPY (2012)
A Comparative Study of Neural and Mesenchymal Stem Cell-Based Carriers for Oncolytic Adenovirus in a Model of Malignant Glioma
Atique U. Ahmed et al.
MOLECULAR PHARMACEUTICS (2011)
Differential Cytopathology and Kinetics of Measles Oncolysis in Two Primary B-cell Malignancies Provides Mechanistic Insights
Bella Patel et al.
MOLECULAR THERAPY (2011)
Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model
Ianko D. Iankov et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer
Evanthia Galanis et al.
CANCER RESEARCH (2010)
Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: No shortcuts on the road to approval
Caroline J. Breitbach et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics
G. Ungerechts et al.
GENE THERAPY (2010)
Systemic Therapy of Disseminated Myeloma in Passively Immunized Mice Using Measles Virus-infected Cell Carriers
Chunsheng Liu et al.
MOLECULAR THERAPY (2010)
Treatment of medulloblastoma with a modified measles virus
Adam W. Studebaker et al.
NEURO-ONCOLOGY (2010)
Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease
Partow Kebriaei et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century
Dianne Pulte et al.
BLOOD (2009)
Dynamics of multiple myeloma tumor therapy with a recombinant measles virus
D. Dingli et al.
CANCER GENE THERAPY (2009)
Mesenchymal Stem Cell Carriers Protect Oncolytic Measles Viruses from Antibody Neutralization in an Orthotopic Ovarian Cancer Therapy Model
Emily K. Mader et al.
CLINICAL CANCER RESEARCH (2009)
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity
E. J. Ilett et al.
GENE THERAPY (2009)
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
Neil N. Senzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer
Laura Vidal et al.
CLINICAL CANCER RESEARCH (2008)
Oncolytic measles virus strains in the treatment of gliomas
Cory Allen et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth
A. Munguia et al.
GENE THERAPY (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
Byeong-Ho Park et al.
LANCET ONCOLOGY (2008)
Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide
R. M. Myers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Lymphoma chemovirotherapy: CD20-Targeted and ConvertaseArmed measles virus can synergize with fludarabine
Guy Ungerechts et al.
CANCER RESEARCH (2007)
Targeted release of oncolytic measles virus by blood outgrowth endothelial cells in situ inhibits orthotopic gliomas
J. Wei et al.
GENE THERAPY (2007)
Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase
Shotaro Iwamoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies
H. T. Ong et al.
GENE THERAPY (2007)
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
Ta-Chiang Liu et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
Adele K. Fielding et al.
BLOOD (2007)
Infected cell carriers: A new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy
Ianko D. Iankov et al.
MOLECULAR THERAPY (2007)
Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity
Cory Allen et al.
CANCER RESEARCH (2006)
A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer
Cari J. McDonald et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model
K. -W. Peng et al.
CANCER GENE THERAPY (2006)
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease
Olle Ringden et al.
TRANSPLANTATION (2006)
Clarification of the nomenclature for MSC: The international society for cellular therapy position statement
EM Horwitz et al.
CYTOTHERAPY (2005)
Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells
L Heinzerling et al.
BLOOD (2005)
Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter
D Dingli et al.
BLOOD (2004)
Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor
KW Peng et al.
GENE THERAPY (2004)
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia
H Kantarjian et al.
CANCER (2004)
Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT:: a GOELAMS trial
M Hunault et al.
BLOOD (2004)
Outcome of treatment in adults with acute lymphoblastic leukemia:: Analysis of the LALA-94 trial
X Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker
KW Peng et al.
BLOOD (2003)
An oncolytic measles virus engineered to enter cells through the CD20 antigen
AD Bucheit et al.
MOLECULAR THERAPY (2003)
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study
J Takeuchi et al.
LEUKEMIA (2002)
Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia
C Linker et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides
KW Peng et al.
NATURE MEDICINE (2002)
Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study
L Annino et al.
BLOOD (2002)
Systemic therapy of myeloma xenografts by an attenuated measles virus
KW Peng et al.
BLOOD (2001)
Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice
D Grote et al.
BLOOD (2001)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Multilineage cells from human adipose tissue: Implications for cell-based therapies
PA Zuk et al.
TISSUE ENGINEERING (2001)
Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen
AL Hammond et al.
JOURNAL OF VIROLOGY (2001)
Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL)
N Gökbuget et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2000)
Recombinant measles viruses efficiently entering cells through targeted receptors
U Schneider et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
